191 related articles for article (PubMed ID: 33886614)
1. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
Choi R; Zhou M; Shek R; Wilson JW; Tillery L; Craig JK; Salukhe IA; Hickson SE; Kumar N; James RM; Buchko GW; Wu R; Huff S; Nguyen TT; Hurst BL; Cherry S; Barrett LK; Hyde JL; Van Voorhis WC
PLoS One; 2021; 16(4):e0250019. PubMed ID: 33886614
[TBL] [Abstract][Full Text] [Related]
2. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.
Canal B; Fujisawa R; McClure AW; Deegan TD; Wu M; Ulferts R; Weissmann F; Drury LS; Bertolin AP; Zeng J; Beale R; Howell M; Labib K; Diffley JFX
Biochem J; 2021 Jul; 478(13):2465-2479. PubMed ID: 34198324
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
[TBL] [Abstract][Full Text] [Related]
4. Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment.
Sixto-López Y; Martínez-Archundia M
J Comput Chem; 2021 May; 42(13):897-907. PubMed ID: 33713492
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
[TBL] [Abstract][Full Text] [Related]
6. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
[TBL] [Abstract][Full Text] [Related]
7. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
[TBL] [Abstract][Full Text] [Related]
8. Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2.
Kim Y; Wower J; Maltseva N; Chang C; Jedrzejczak R; Wilamowski M; Kang S; Nicolaescu V; Randall G; Michalska K; Joachimiak A
Commun Biol; 2021 Feb; 4(1):193. PubMed ID: 33564093
[TBL] [Abstract][Full Text] [Related]
9. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
[TBL] [Abstract][Full Text] [Related]
10. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.
Canal B; McClure AW; Curran JF; Wu M; Ulferts R; Weissmann F; Zeng J; Bertolin AP; Milligan JC; Basu S; Drury LS; Deegan TD; Fujisawa R; Roberts EL; Basier C; Labib K; Beale R; Howell M; Diffley JFX
Biochem J; 2021 Jul; 478(13):2445-2464. PubMed ID: 34198326
[TBL] [Abstract][Full Text] [Related]
11. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
Batool A; Bibi N; Amin F; Kamal MA
Eur J Pharmacol; 2021 Feb; 892():173779. PubMed ID: 33275961
[TBL] [Abstract][Full Text] [Related]
12. Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations.
Zrieq R; Ahmad I; Snoussi M; Noumi E; Iriti M; Algahtani FD; Patel H; Saeed M; Tasleem M; Sulaiman S; Aouadi K; Kadri A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639036
[TBL] [Abstract][Full Text] [Related]
13. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase.
Basu S; Mak T; Ulferts R; Wu M; Deegan T; Fujisawa R; Tan KW; Lim CT; Basier C; Canal B; Curran JF; Drury LS; McClure AW; Roberts EL; Weissmann F; Zeisner TU; Beale R; Cowling VH; Howell M; Labib K; Diffley JFX
Biochem J; 2021 Jul; 478(13):2481-2497. PubMed ID: 34198328
[TBL] [Abstract][Full Text] [Related]
14. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease.
Milligan JC; Zeisner TU; Papageorgiou G; Joshi D; Soudy C; Ulferts R; Wu M; Lim CT; Tan KW; Weissmann F; Canal B; Fujisawa R; Deegan T; Nagaraj H; Bineva-Todd G; Basier C; Curran JF; Howell M; Beale R; Labib K; O'Reilly N; Diffley JFX
Biochem J; 2021 Jul; 478(13):2499-2515. PubMed ID: 34198327
[TBL] [Abstract][Full Text] [Related]
15. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
16. Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.
Pearson LA; Green CJ; Lin D; Petit AP; Gray DW; Cowling VH; Fordyce EAF
SLAS Discov; 2021 Jul; 26(6):749-756. PubMed ID: 33724070
[TBL] [Abstract][Full Text] [Related]
17. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
Watashi K
Biochem Biophys Res Commun; 2021 Jan; 538():137-144. PubMed ID: 33272566
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19.
Chandra A; Gurjar V; Qamar I; Singh N
J Biomol Struct Dyn; 2021 Aug; 39(12):4201-4211. PubMed ID: 32462970
[TBL] [Abstract][Full Text] [Related]
19. Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease.
Chen J; Farraj RA; Limonta D; Tabatabaei Dakhili SA; Kerek EM; Bhattacharya A; Reformat FM; Mabrouk OM; Brigant B; Pfeifer TA; McDermott MT; Ussher JR; Hobman TC; Glover JNM; Hubbard BP
J Biol Chem; 2023 Nov; 299(11):105341. PubMed ID: 37832873
[TBL] [Abstract][Full Text] [Related]
20.
Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]